PT3038654T - Nova utilização - Google Patents

Nova utilização

Info

Publication number: PT3038654T
Authority: PT; Portugal
Prior art keywords: new use; new
Prior art date: 2013-08-26

Application number

PT147617021T

Other languages

English (en)

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-26

Filing date

2014-08-26

Publication date

2020-02-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51494327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3038654(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-08-26 Priority claimed from PCT/US2013/056680 external-priority patent/WO2015030711A1/en

2014-08-26 Application filed by Novartis Ag filed Critical Novartis Ag

2020-02-04 Publication of PT3038654T publication Critical patent/PT3038654T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

PT147617021T 2013-08-26 2014-08-26 Nova utilização PT3038654T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/US2013/056680 WO2015030711A1 (en)	2013-08-26	2013-08-26	New use
US201461972933P	2014-03-31	2014-03-31

Publications (1)

Publication Number	Publication Date
PT3038654T true PT3038654T (pt)	2020-02-04

Family

ID=51494327

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PT147617021T PT3038654T (pt)	2013-08-26	2014-08-26	Nova utilização
PT232021907T PT4321157T (pt)	2013-08-26	2014-08-26	Nova utilização de uma combinação de um bloqueador dos recetores da angiotensina (arb) com um inibidor da endopeptidase neutra (nepi)
PT192028546T PT3626270T (pt)	2013-08-26	2014-08-26	Tratamento de doenças cardiovasculares

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
PT232021907T PT4321157T (pt)	2013-08-26	2014-08-26	Nova utilização de uma combinação de um bloqueador dos recetores da angiotensina (arb) com um inibidor da endopeptidase neutra (nepi)
PT192028546T PT3626270T (pt)	2013-08-26	2014-08-26	Tratamento de doenças cardiovasculares

Country Status (16)

Country	Link
US (2)	US20160213646A1 (pt)
EP (4)	EP3038654B1 (pt)
JP (1)	JP6097888B2 (pt)
CY (1)	CY1122531T1 (pt)
DK (3)	DK3626270T3 (pt)
ES (3)	ES3001196T3 (pt)
FI (2)	FI4321157T3 (pt)
HR (3)	HRP20241763T1 (pt)
HU (3)	HUE047186T2 (pt)
LT (3)	LT3038654T (pt)
PL (3)	PL3626270T3 (pt)
PT (3)	PT3038654T (pt)
RS (3)	RS65037B1 (pt)
SI (3)	SI3626270T1 (pt)
SM (1)	SMT202500001T1 (pt)
WO (1)	WO2015028941A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE047186T2 (hu)	2013-08-26	2020-04-28	Novartis Ag	Új alkalmazás
EP3253740A1 (en) *	2015-02-06	2017-12-13	Mylan Laboratories Ltd.	Amorphous trisodium sacubitril valsartan and a process for the preparation thereof
US20180140579A1 (en) *	2015-05-29	2018-05-24	Novartis Ag	Sacubitril and valsartan for treating metabolic disease
CN106309388A (zh) *	2015-06-30	2017-01-11	深圳信立泰药业股份有限公司	一种用于心衰治疗的药物组合物及其制备方法
WO2017036420A1 (zh) *	2015-09-06	2017-03-09	常州方楠医药技术有限公司	含沙库比曲和缬沙坦的药用组合物及其制备方法
CN106491600A (zh) *	2015-09-06	2017-03-15	常州方楠医药技术有限公司	无定型沙库区比、缬沙坦或其药学上可接受的盐与药用辅料的组合物及其制备方法
CN107510653A (zh) *	2016-06-17	2017-12-26	常州爱诺新睿医药技术有限公司	一种含有无定型沙库比曲和缬沙坦的固体分散体的药用组合物及其制备方法
WO2017042700A1 (en) *	2015-09-07	2017-03-16	Sun Pharmaceutical Industries Limited	Solid forms of valsartan and sacubitril
WO2017063581A1 (zh) *	2015-10-16	2017-04-20	深圳信立泰药业股份有限公司	一种用于心血管疾病治疗的口服制剂及其制备方法
CN105330609B (zh) *	2015-12-07	2017-12-22	南京正大天晴制药有限公司	一种制备lcz696的方法
EP3411018A1 (en)	2016-02-03	2018-12-12	Novartis AG	Galenic formulations of organic compounds
CN106176681A (zh) *	2016-08-25	2016-12-07	泰力特医药（湖北）有限公司	一种抗心脏衰竭药物lcz696口服缓释微丸及其制备方法
US11382866B2 (en)	2017-07-06	2022-07-12	Mankind Pharma Ltd.	Fixed dose pharmaceutical composition of valsartan and sacubitril
WO2020039386A1 (en)	2018-08-23	2020-02-27	Novartis Ag	New pharmaceutical use for the treatment of heart failure
WO2020039394A1 (en)	2018-08-24	2020-02-27	Novartis Ag	New drug combinations
JP7316449B2 (ja) *	2019-09-20	2023-07-27	シェンヅェンサルブリスファーマシューティカルズカンパニーリミテッド	心不全治療におけるアンジオテンシンｉｉ受容体アンタゴニスト代謝産物とｎｅｐ阻害剤との複合体の使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL97219A (en)	1990-02-19	1995-12-08	Ciba Geigy Ag	Biphenyl substituted aliphatic amino compounds process for their preparation and pharmaceutical compositions containing them
US5217996A (en)	1992-01-22	1993-06-08	Ciba-Geigy Corporation	Biaryl substituted 4-amino-butyric acid amides
CN1249682A (zh) *	1997-01-10	2000-04-05	麦克公司	用于治疗有症状的心力哀竭的血管紧张素ⅱ拮抗剂
ES2290429T3 (es)	2002-01-17	2008-02-16	Novartis Ag	Composiciones farmaceuticas que comprenden valsartan e inhibidores de nep.
AU2004238546A1 (en) *	2003-05-16	2004-11-25	Novartis Ag	Pharmaceutical composition comprising valsartan
AR057882A1 (es) *	2005-11-09	2007-12-26	Novartis Ag	Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
WO2009061713A1 (en)	2007-11-06	2009-05-14	Novartis Ag	Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor
KR20170015525A (ko)	2008-11-22	2017-02-08	제넨테크, 인크.	유방암의 치료를 위한, 화학요법과 조합된 항-ｖｅｇｆ 항체의 용도
EP2608784B1 (en) *	2010-08-24	2018-09-19	Novartis AG	Treatment or prevention of heart failure in a mammal receiving anti-coagulant therapy
EP3943084A1 (en)	2012-08-24	2022-01-26	Novartis AG	Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling
HUE047186T2 (hu)	2013-08-26	2020-04-28	Novartis Ag	Új alkalmazás
WO2015030711A1 (en) *	2013-08-26	2015-03-05	Novartis Ag	New use

2014
- 2014-08-26 HU HUE14761702A patent/HUE047186T2/hu unknown
- 2014-08-26 PL PL19202854.6T patent/PL3626270T3/pl unknown
- 2014-08-26 DK DK19202854.6T patent/DK3626270T3/da active
- 2014-08-26 PT PT147617021T patent/PT3038654T/pt unknown
- 2014-08-26 EP EP14761702.1A patent/EP3038654B1/en not_active Revoked
- 2014-08-26 HR HRP20241763TT patent/HRP20241763T1/hr unknown
- 2014-08-26 DK DK23202190.7T patent/DK4321157T3/da active
- 2014-08-26 EP EP23202190.7A patent/EP4321157B1/en active Active
- 2014-08-26 PT PT232021907T patent/PT4321157T/pt unknown
- 2014-08-26 LT LTEP14761702.1T patent/LT3038654T/lt unknown
- 2014-08-26 EP EP24206614.0A patent/EP4512397A3/en active Pending
- 2014-08-26 HR HRP20240034TT patent/HRP20240034T1/hr unknown
- 2014-08-26 SM SM20250001T patent/SMT202500001T1/it unknown
- 2014-08-26 RS RS20240031A patent/RS65037B1/sr unknown
- 2014-08-26 ES ES23202190T patent/ES3001196T3/es active Active
- 2014-08-26 SI SI201432059T patent/SI3626270T1/sl unknown
- 2014-08-26 RS RS20241359A patent/RS66371B1/sr unknown
- 2014-08-26 FI FIEP23202190.7T patent/FI4321157T3/fi active
- 2014-08-26 HR HRP20200060TT patent/HRP20200060T1/hr unknown
- 2014-08-26 US US14/914,005 patent/US20160213646A1/en not_active Abandoned
- 2014-08-26 DK DK14761702.1T patent/DK3038654T3/da active
- 2014-08-26 SI SI201432099T patent/SI4321157T1/sl unknown
- 2014-08-26 ES ES14761702T patent/ES2767084T3/es active Active
- 2014-08-26 PT PT192028546T patent/PT3626270T/pt unknown
- 2014-08-26 RS RS20200047A patent/RS59816B1/sr unknown
- 2014-08-26 FI FIEP19202854.6T patent/FI3626270T3/fi active
- 2014-08-26 HU HUE23202190A patent/HUE069419T2/hu unknown
- 2014-08-26 WO PCT/IB2014/064074 patent/WO2015028941A1/en not_active Ceased
- 2014-08-26 LT LTEP19202854.6T patent/LT3626270T/lt unknown
- 2014-08-26 ES ES19202854T patent/ES2968541T3/es active Active
- 2014-08-26 HU HUE19202854A patent/HUE064634T2/hu unknown
- 2014-08-26 EP EP19202854.6A patent/EP3626270B1/en active Active
- 2014-08-26 PL PL14761702T patent/PL3038654T3/pl unknown
- 2014-08-26 PL PL23202190.7T patent/PL4321157T3/pl unknown
- 2014-08-26 JP JP2016537414A patent/JP6097888B2/ja active Active
- 2014-08-26 LT LTEP23202190.7T patent/LT4321157T/lt unknown
- 2014-08-26 SI SI201431464T patent/SI3038654T1/sl unknown
2020
- 2020-01-28 CY CY20201100075T patent/CY1122531T1/el unknown
- 2020-11-24 US US17/103,327 patent/US20210077461A1/en active Pending

Also Published As

Publication number	Publication date
EP3626270B1 (en)	2023-10-11
EP4321157A2 (en)	2024-02-14
RS65037B1 (sr)	2024-02-29
FI3626270T3 (fi)	2024-01-11
DK3626270T3 (da)	2024-01-15
PL3626270T3 (pl)	2024-04-08
DK4321157T3 (da)	2024-12-16
RS66371B1 (sr)	2025-02-28
SI3626270T1 (sl)	2024-03-29
ES2767084T3 (es)	2020-06-16
EP3038654B1 (en)	2019-10-30
ES2968541T3 (es)	2024-05-10
EP4512397A2 (en)	2025-02-26
ES3001196T3 (es)	2025-03-04
PL3038654T3 (pl)	2020-05-18
PL4321157T3 (pl)	2025-03-03
HUE069419T2 (hu)	2025-03-28
LT3626270T (lt)	2024-01-25
RS59816B1 (sr)	2020-02-28
CY1122531T1 (el)	2021-01-27
PT3626270T (pt)	2024-01-11
WO2015028941A1 (en)	2015-03-05
HRP20240034T1 (hr)	2024-03-29
SMT202500001T1 (it)	2025-03-12
DK3038654T3 (da)	2020-02-03
EP4512397A3 (en)	2025-05-14
HRP20241763T1 (hr)	2025-03-14
PT4321157T (pt)	2025-01-08
EP3626270A1 (en)	2020-03-25
FI4321157T3 (fi)	2025-01-20
HUE064634T2 (hu)	2024-04-28
EP4321157B1 (en)	2024-10-23
HRP20200060T1 (hr)	2020-04-03
US20210077461A1 (en)	2021-03-18
JP6097888B2 (ja)	2017-03-15
EP4321157A3 (en)	2024-05-15
US20160213646A1 (en)	2016-07-28
SI4321157T1 (sl)	2025-03-31
HUE047186T2 (hu)	2020-04-28
LT4321157T (lt)	2025-01-10
LT3038654T (lt)	2020-01-27
SI3038654T1 (sl)	2020-02-28
EP3038654A1 (en)	2016-07-06
JP2016528303A (ja)	2016-09-15

Publication	Publication Date	Title
DK3689865T3 (en)	2023-06-19	Hidtil ukendte aminopyrimidinderivater
DK3354246T3 (en)	2020-02-03	Udstyrsmonteringssystem
GB201305825D0 (en)	2013-05-15	New use
HUE047186T2 (hu)	2020-04-28	Új alkalmazás
GB201405503D0 (en)	2014-05-14	Novel Use
GB201304236D0 (en)	2013-04-24	Hand-warmer
AU353643S (en)	2014-02-12	Stamphousing
GB201301617D0 (en)	2013-03-13	T-Monitor
DK2989854T3 (en)	2022-08-08	Strømstyret opvarmningssystem
GB201321223D0 (en)	2014-01-15	Novel use
GB201321218D0 (en)	2014-01-15	Novel use
GB201319824D0 (en)	2013-12-25	Novel use
GB201319828D0 (en)	2013-12-25	Novel use
GB201318414D0 (en)	2013-12-04	Novel use
GB201318415D0 (en)	2013-12-04	Novel use
AU353329S (en)	2014-01-21	Kettlebell
AU353327S (en)	2014-01-21	Kettlebell
GB201318654D0 (en)	2013-12-04	Holdlock
GB201317068D0 (en)	2013-11-06	P-Pop
GB201316804D0 (en)	2013-11-06	C-mtv
GB201315908D0 (en)	2013-10-23	Insugrip
GB201315332D0 (en)	2013-10-09	Drivesafe
GB201313996D0 (en)	2013-09-18	Tradepad
GB201313766D0 (en)	2013-09-18	Attach-A-Bag
GB201313646D0 (en)	2013-09-11	HarmicGo - harmonica